ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

Clinical trial NCT05653271 · COMPLETED

Trial details

NCT number: NCT05653271
Sponsor: Acepodia Biotech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma Non Hodgkin Lymphoma DLBCL Primary Mediastinal Large B Cell Lymphoma Marginal Zone Lymphoma Follicular Lymphoma Burkitt Lymphoma High-grade B-cell Lymphoma

Start date: 2023-01-21
Primary completion: 2026-03-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.